Skip to main content
Clinical Trials/NL-OMON50536
NL-OMON50536
Completed
N/A

Discovery and validation of diagnostic biomarkers for left ventricular diastolic dysfunction and HEart faiLure with Preserved ejection Fraction - HELPFul study

niversitair Medisch Centrum Utrecht0 sites977 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diastolic Heart Failure
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
977
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 5, 2023
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • \- Patients in the cardiology outpatient clinic of Cardiology Centre
  • Netherlands, Diakonessenhuis Utrecht or HeartLife Klinieken Utrecht who
  • receive cardial screening, including an echocardiography, because of general
  • practitioner\*s request
  • \- Age 45 year and older
  • \- Patient is willing and able to provide written informed consent for
  • participation in this study
  • \- The inclusion criteria match the criteria for diagnosis of diastolic
  • dysfunction or HFpEF., Additional ARGUS, Inclusion criteria ARGUS
  • In order to be eligible to participate in the ARGUS study, a subject must meet

Exclusion Criteria

  • Patients from whom no informed consent is obtained
  • Incapacitated adults: language barriers or other obstacles for full
  • understanding of the study objectives
  • Patients with former cardiac procedures.
  • Patients with congenital heart disease,
  • Additional ARGUS:
  • A potential subject who meets any of the mentioned criteria or any of the
  • following will be excluded from participation in the ARGUS study:
  • Patients for whom (a part of) the cardiac CT study protocol is contra
  • indicated prior to inclusion (if CT is contra indicated after completion of

Outcomes

Primary Outcomes

Not specified

Similar Trials